TimesSquare Capital Management LLC bought a new position in shares of The Allstate Co. (NYSE:ALL - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 410,328 shares of the insurance provider's stock, valued at approximately $77,819,000. Allstate accounts for 1.2% of TimesSquare Capital Management LLC's investment portfolio, making the stock its 23rd biggest position. TimesSquare Capital Management LLC owned about 0.15% of Allstate at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in ALL. GSA Capital Partners LLP bought a new stake in shares of Allstate during the 1st quarter worth approximately $566,000. Csenge Advisory Group acquired a new stake in Allstate in the first quarter valued at approximately $213,000. Oppenheimer & Co. Inc. lifted its holdings in Allstate by 2.0% during the first quarter. Oppenheimer & Co. Inc. now owns 11,621 shares of the insurance provider's stock worth $2,011,000 after acquiring an additional 227 shares during the period. Atomi Financial Group Inc. raised its stake in shares of Allstate by 16.6% in the first quarter. Atomi Financial Group Inc. now owns 2,019 shares of the insurance provider's stock valued at $349,000 after buying an additional 288 shares during the period. Finally, Fiduciary Family Office LLC raised its stake in shares of Allstate by 21.5% in the first quarter. Fiduciary Family Office LLC now owns 2,701 shares of the insurance provider's stock valued at $467,000 after buying an additional 478 shares during the period. Institutional investors own 76.47% of the company's stock.
Insider Activity at Allstate
In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the firm's stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the sale, the executive vice president now owns 19,163 shares of the company's stock, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $179.09, for a total value of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares in the company, valued at $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Thomas J. Wilson sold 90,000 shares of the business's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the sale, the chief executive officer now owns 88,552 shares in the company, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 192,530 shares of company stock worth $34,967,665 in the last ninety days. Company insiders own 1.80% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on ALL. Wells Fargo & Company boosted their target price on Allstate from $175.00 to $186.00 and gave the company an "equal weight" rating in a research note on Tuesday, November 5th. Morgan Stanley upped their price objective on Allstate from $220.00 to $228.00 and gave the stock an "overweight" rating in a research note on Thursday. TD Cowen increased their price target on Allstate from $193.00 to $224.00 and gave the stock a "buy" rating in a research note on Tuesday, September 3rd. The Goldman Sachs Group raised their price objective on Allstate from $199.00 to $204.00 and gave the company a "buy" rating in a research report on Thursday, August 15th. Finally, Piper Sandler increased their price target on shares of Allstate from $188.00 to $196.00 and gave the company an "overweight" rating in a report on Friday, August 16th. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $212.56.
Check Out Our Latest Research Report on Allstate
Allstate Stock Up 3.3 %
ALL traded up $6.35 during midday trading on Friday, hitting $196.90. 2,018,725 shares of the company's stock traded hands, compared to its average volume of 1,555,754. The Allstate Co. has a one year low of $128.33 and a one year high of $198.79. The company has a market cap of $52.14 billion, a PE ratio of 12.75, a price-to-earnings-growth ratio of 1.76 and a beta of 0.48. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The stock's fifty day simple moving average is $189.09 and its 200-day simple moving average is $175.85.
Allstate (NYSE:ALL - Get Free Report) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company had revenue of $16.63 billion for the quarter, compared to the consensus estimate of $14.57 billion. During the same quarter in the previous year, the company earned $0.81 EPS. The firm's revenue for the quarter was up 14.7% compared to the same quarter last year. As a group, equities analysts anticipate that The Allstate Co. will post 15.34 earnings per share for the current fiscal year.
About Allstate
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.